Schizophrenia News and Research

Latest Schizophrenia News and Research

CDSS best for assessing depression symptoms in schizophrenia

Results from a systematic review of published studies suggests that the Calgary Depression Scale for Schizophrenia is the most reliable and valid instrument for assessing depression symptoms in patients with schizophrenia.

21 Jun 2012

Study to test NAC and aspirin for people diagnosed with bipolar disorder

A commonly available pharmaceutical drug with anti-inflammatory properties and a nutritional supplement thought to have antioxidant effects are now being tested at The University of Texas Health Science Center at Houston (UTHealth) as add-on therapies for people diagnosed with bipolar disorder.

21 Jun 2012

Childhood viral CNS infections increase psychosis risk

Viral infections of the central nervous system in childhood are associated with nearly a two-fold increased risk for non-affective psychosis and schizophrenia in adulthood, a review and meta-analysis of published studies shows.

20 Jun 2012

Insight linked to gray matter volume in FEP patients

Results from an Irish study show that poor insight is associated with increased gray matter volume in subcortical and frontotemporal brain regions among patients with first-episode psychosis, but not in those with chronic schizophrenia.

20 Jun 2012

Study identifies critical neurological factor in aggression

Pathological rage can be blocked in mice, researchers have found, suggesting potential new treatments for severe aggression, a widespread trait characterized by sudden violence, explosive outbursts and hostile overreactions to stress.

20 Jun 2012

New approach to decipher roles of genes associated with autism

Fish cannot display symptoms of autism, schizophrenia or other human brain disorders. However, a team of MIT biologists has shown that zebrafish can be a useful tool for studying the genes that contribute to such disorders.

20 Jun 2012

Five abstracts evaluating Abbott's LCIG presented at Parkinson's disease congress

Today Abbott announced results from five abstracts evaluating levodopa-carbidopa intestinal gel (LCIG), its investigational compound for advanced Parkinson's disease.

19 Jun 2012

Health Canada approves Sunovion’s LATUDA NDA to treat schizophrenia

Sunovion Pharmaceuticals Canada Inc. today announced that the New Drug Submission (NDS) for LATUDA (lurasidone HCl), for the treatment of adult patients with acute schizophrenia has been approved by Health Canada.

16 Jun 2012

Emotion perception impaired in patients at risk for psychosis

Patients at ultra-high risk for psychosis, as well as those with first-episode schizophrenia, show significant impairments in facial and vocal emotion recognition, researchers report.

15 Jun 2012

Oxidative stress linked to NSS severity in schizophrenia

The severity of neurologic soft signs negatively correlates with antioxidant superoxide dismutase activity in patients with schizophrenia, research shows.

14 Jun 2012

Preterm birth increases psychiatric disorder risk

Individuals born preterm are at increased risk for a range of psychiatric disorders in young adulthood, researchers report.

14 Jun 2012

IBMT linked with positive structural changes in brain connectivity

A Texas Tech University scientist studying the Chinese mindfulness meditation known as integrative body-mind training (IBMT) said he and other researchers have confirmed and expanded on changes in structural efficiency of white matter in the brain that can be related to positive behavioral changes in subjects practicing the technique for a month and a minimum of 11 hours total.

14 Jun 2012

Researchers use brain imaging to uncover susceptibility to psychological stress and trauma

Most people have intense emotional reactions to traumatizing events like road accidents or combat. But some suffer far longer, caught in the grip of long-term debilitating disorders such as Post-Traumatic Stress Disorder (PTSD). Because doctors cannot predict who will develop these disorders, however, early or preventive intervention is not available. Now, a new project led by researchers at Tel Aviv University seeks to identify pre-traumatic subjects - those who are more susceptible to long-standing disorders if exposed to a traumatic incident.

14 Jun 2012

EnVivo to present results from EVP-6124 Phase 2b trial on AD at AAIC 2012

EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, today announced that the company will present a comprehensive analysis of its recently completed Phase 2b clinical trial of EVP-6124 in Alzheimer's disease at the Alzheimer's Association International Conference 2012 (AAIC), being held July 14-19, 2012 in Vancouver, British Columbia.

14 Jun 2012

Hot weather increases death risk in psychosis patients

Hot weather is associated with increased mortality rates among patients with psychosis, dementia, or substance use disorder, UK research shows.

13 Jun 2012

Specific personality traits linked to suicide risk in schizophrenia

Patients with schizophrenia who have a history of suicide attempts show a different pattern of temperament and character traits compared with their nonsuicidal counterparts, say Turkish researchers.

12 Jun 2012

Epo has performance-enhancing effect on brain, may help treat depression, schizophrenia

Sportsmen and women dope with the blood hormone Epo to enhance their performance. Researchers from the University of Zurich now discovered by animal testing that Epo has a performance-enhancing effect in the brain shortly after injection and not only after days by improving oxygen transport in blood. As Epo also increases motivation, it could be useful in treating depression.

11 Jun 2012

Amylin, Alkermes announce results from BYDUREON clinical study on type 2 diabetes

Amylin Pharmaceuticals, Inc. and Alkermes plc today announced results from the long-term extension of the DURATION-1 study, which showed that BYDUREON (exenatide extended-release for injectable suspension), the first and only once-weekly treatment for type 2 diabetes, was associated with clinically significant and sustained improvements in glycemic control during four years of treatment in adults with type 2 diabetes.

11 Jun 2012

Eye-viewing tests identify schizophrenic patients

Viewing tests that detect eye movement can accurately identify patients with schizophrenia, research shows.

8 Jun 2012

'Coolness' loses much of its historical origins

Research led by a University of Rochester Medical Center psychologist and published by the Journal of Individual Differences has found the characteristics associated with coolness today are markedly different than those that generated the concept of cool.

8 Jun 2012